The FDA’s anticipated approval of the first coronavirus vaccine enables scientists to kick off studies examining whether “forever chemicals” hinder the effectiveness of Covid-19 vaccines.
But studies set to go when vaccines reach their local communities aren’t big enough to shed light on what the Centers for Disease Control and Prevention has already said is an important question facing communities: how exposure to per- and polyfluoroalkyl substances may affect their risk of getting infected by Covid-19.
The ubiquitous and persistent chemicals known as PFAS have made it from factories and products into air, and the bloodstreams of 95% of Americans. ...